Latest Articles

Publication Date
All News Scientific
Observational Data Challenge p53 Expression as a Surrogate Marker for TP53 Mutations in High-Risk Endometrial Cancer - OncLive

Observational Data Challenge p53 Expression as a Surrogate Marker for TP53 Mutations in High-Risk Endometrial Cancer OncLive

Published: Jan. 30, 2025, 10:29 p.m.
Read Full Article
Selinexor May Confer PFS Benefit in TP53 Wild-Type Endometrial Cancer - OncLive

Selinexor May Confer PFS Benefit in TP53 Wild-Type Endometrial Cancer OncLive

Published: Nov. 4, 2024, 8:08 p.m.
Read Full Article
Karyopharm Presents Updated Exploratory Subgroup Analyses from SIENDO Study in Patients with Advanced or Recurrent TP53 Wild-Type Endometrial Cancer During 2024 ASCO Plenary Series: Rapid Abstract Updates - PR Newswire

Karyopharm Presents Updated Exploratory Subgroup Analyses from SIENDO Study in Patients with Advanced or Recurrent TP53 Wild-Type Endometrial Cancer During 2024 ASCO Plenary Series: Rapid Abstract Updates PR Newswire

Published: June 1, 2024, 7 a.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!